These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 2731989)
1. Identification of functional antigenic segments of toxic shock syndrome toxin 1 by differential immunoreactivity and by differential mitogenic responses of human peripheral blood mononuclear cells, using active toxin fragments. Edwin C; Kass EH Infect Immun; 1989 Jul; 57(7):2230-6. PubMed ID: 2731989 [TBL] [Abstract][Full Text] [Related]
2. Determination of biologically active region in toxic shock syndrome toxin 1. Kokan-Moore NP; Bergdoll MS Rev Infect Dis; 1989; 11 Suppl 1():S125-9. PubMed ID: 2467343 [TBL] [Abstract][Full Text] [Related]
3. Localization of biologic functions of toxic shock syndrome toxin-1 by use of monoclonal antibodies and cyanogen bromide-generated toxin fragments. Blomster-Hautamaa DA; Novick RP; Schlievert PM J Immunol; 1986 Dec; 137(11):3572-6. PubMed ID: 3782792 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship of toxic-shock-syndrome toxin-1: derivation and characterization of immunologically and biologically active fragments. Edwin C; Parsonnet J; Kass EH J Infect Dis; 1988 Dec; 158(6):1287-95. PubMed ID: 3198939 [TBL] [Abstract][Full Text] [Related]
5. Activation of in vitro proliferation of human T cells by a synthetic peptide of toxic shock syndrome toxin 1. Edwin C; Swack JA; Williams K; Bonventre PF; Kass EH J Infect Dis; 1991 Mar; 163(3):524-9. PubMed ID: 1995725 [TBL] [Abstract][Full Text] [Related]
6. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Bonventre PF; Heeg H; Cullen C; Lian CJ Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody. Pang LT; Kum WW; Chow AW Infect Immun; 2000 Jun; 68(6):3261-8. PubMed ID: 10816471 [TBL] [Abstract][Full Text] [Related]
8. Effect of chemical modification of histidine and tyrosine residues in toxic shock syndrome toxin 1 on the serologic and mitogenic activities of the toxin. Kokan-Moore NP; Bergdoll MS Infect Immun; 1989 Jul; 57(7):1901-5. PubMed ID: 2499540 [TBL] [Abstract][Full Text] [Related]
9. Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo. Bonventre PF; Thompson MR; Adinolfi LE; Gillis ZA; Parsonnet J Infect Immun; 1988 Jan; 56(1):135-41. PubMed ID: 3257201 [TBL] [Abstract][Full Text] [Related]
10. Localization of a biologically important epitope on toxic-shock-syndrome toxin-1. Murphy BG; Kreiswirth BN; Novick RP; Schlievert PM J Infect Dis; 1988 Sep; 158(3):549-55. PubMed ID: 2457635 [TBL] [Abstract][Full Text] [Related]
11. Biological and immunological properties of the carboxyl terminus of staphylococcal enterotoxin C1. Bohach GA; Handley JP; Schlievert PM Infect Immun; 1989 Jan; 57(1):23-8. PubMed ID: 2909489 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the mitogenic effects of toxic shock toxin on human peripheral blood mononuclear cells in vitro. Calvano SE; Quimby FW; Antonacci AC; Reiser RF; Bergdoll MS; Dineen P Clin Immunol Immunopathol; 1984 Oct; 33(1):99-110. PubMed ID: 6332701 [TBL] [Abstract][Full Text] [Related]
13. Role of a carboxy-terminal site of toxic shock syndrome toxin 1 in eliciting immune responses of human peripheral blood mononuclear cells. Drynda A; König B; Bonventre PF; König W Infect Immun; 1995 Mar; 63(3):1095-101. PubMed ID: 7532624 [TBL] [Abstract][Full Text] [Related]
15. Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody. Blanco L; Choi EM; Connolly K; Thompson MR; Bonventre PF Infect Immun; 1990 Sep; 58(9):3020-8. PubMed ID: 1696937 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1. Kum WW; Chow AW J Infect Dis; 2001 Jun; 183(12):1739-48. PubMed ID: 11372026 [TBL] [Abstract][Full Text] [Related]
17. Effects of monoclonal antibody on biologic function of toxic shock syndrome toxin 1 in vitro and in vivo. Parsonnet J; Gillis ZA; Thompson MR; Adinolfi L; Bonventre PF Rev Infect Dis; 1989; 11 Suppl 1():S318-9. PubMed ID: 2928650 [No Abstract] [Full Text] [Related]
18. A toxic shock syndrome toxin-1 peptide that shows homology to mycobacterial heat shock protein 18 is presented as conventional antigen to T cells by multiple HLA-DR alleles. Ramesh N; Spertini F; Scholl P; Geha R J Immunol; 1992 Feb; 148(4):1025-30. PubMed ID: 1737925 [TBL] [Abstract][Full Text] [Related]
19. Localisation of the mitogenic epitope of staphylococcal enterotoxin B. Binek M; Newcomb JR; Rogers CM; Rogers TJ J Med Microbiol; 1992 Mar; 36(3):156-63. PubMed ID: 1372360 [TBL] [Abstract][Full Text] [Related]
20. Epitope mapping of neutralizing TSST-1 specific antibodies induced by immunization with toxin or toxoids. Gampfer JM; Samstag A; Waclavicek M; Wolf HM; Eibl MM; Gulle H Vaccine; 2002 Nov; 20(31-32):3675-84. PubMed ID: 12399195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]